As 2019 rolls in, we expect to see a flurry of approvals in the Japanese regenerative medicine arena, with regulatory decisions anticipated by the end of the year for Novartis Pharma’s CAR-T therapy and many more products, which could bring…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS Big Takeda Could Debut as Early as January 8, De-facto Vote on Shire Deal Set for Dec. 5
November 13, 2018
-
BUSINESS Takeda: De-facto Vote on Shire Deal Set for Dec. 5
November 12, 2018
-
BUSINESS Japan Is Top Strategic Market for Biogen: CEO
November 12, 2018
-
ORGANIZATION 7 EFPIA Companies Revised R&D Strategies after April Pricing Overhaul: Survey
November 9, 2018
-
REGULATORY LDP Health Bigwigs Agree to Push for October 2019 Revision
November 9, 2018
-
REGULATORY MHLW Pitches “Tiered Model” for CEA Price Tweak, but Faces Chuikyo Opposition
November 8, 2018
-
REGULATORY FY2019 Tax Reform Debate Going into Full Swing; Will Pharma Industry Win Expansion in R&D Credit?
November 7, 2018
-
ORGANIZATION Wrong Policies Could Drive Investments Out of Japan amid China’s Rise, PhRMA Int’l Advocacy Chief Warns
November 6, 2018
-
BUSINESS Balancing Act: All Eyes on Nesp Biosame Pricing before June 2019 Listing, Biosimilars to Follow in November
November 5, 2018
-
BUSINESS 8 Major Drug Makers See Flat Sales in 1st Half; Overseas Growth Continues to Compensate for Slumping Japan Revenue
November 5, 2018
-
REGULATORY LDP’s Eto Study Group Opposes 2-Stage Revision in 2019
November 2, 2018
-
REGULATORY Chuikyo Leaning towards Drug Price Revision in October 2019 in Conjunction with Tax Hike
November 1, 2018
-
REGULATORY Infection Specialist Proposes to Set Up Vaccination Council within Cabinet Office
October 31, 2018
-
BUSINESS Shionogi Chief Confident about 70% Market Share for Xofluza in Japan
October 30, 2018
-
ORGANIZATION Limit CEA Application to Premium-Given Drugs with Big Sales: EFPIA Japan Officials
October 29, 2018
-
ORGANIZATION EFPIA Japan Chief Eyes New Funding Model for Innovative but Pricey Therapies
October 26, 2018
-
BUSINESS Tecentriq, Hemlibra Get Off with a Bang, Clear 2018 Targets Already: Chugai
October 25, 2018
-
BUSINESS AVXS-101 Is Game Changer for SMA Treatment: Novartis Neuroscience Chief
October 24, 2018
-
BUSINESS Parexel CEO Sees Bright Future for Japan CRO Market
October 23, 2018
-
BUSINESS Mundipharma Shooting for Japan Sales of US$500 Million in 10 Years: CEO
October 22, 2018
ページ
Takeda Pharmaceutical completed the £46 billion acquisition of Shire on January 8, vaulting itself into the top 10 league of…
To many people, Japan has always been one of the world’s most advanced economies and a market of rich opportunities with one of the top healthcare systems worldwide.Add a rapidly changing demographic, a declining workforce, and the constant challenges of…
While generic drugs post solid growth in volume-based shares in Japan, their makers are pondering ways to retool their business…